Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab

PHASE3CompletedINTERVENTIONAL
Enrollment

770

Participants

Timeline

Start Date

November 24, 2014

Primary Completion Date

March 9, 2018

Study Completion Date

March 9, 2018

Conditions
Hypercholesterolemia
Interventions
BIOLOGICAL

Evolocumab

Administered by subcutaneous injection once a month

Trial Locations (126)

101

Research Site, Reykjavik

251

Research Site, New Taipei City

1023

Research Site, Budapest

1122

Research Site, Budapest

1134

Research Site, Budapest

1211

Research Site, Geneva

2020

Research Site, Antwerp

2157

Research Site, Sunninghill

2170

Research Site, Liverpool

2305

Research Site, New Lambton Heights

2650

Research Site, Edegem

3011

Research Site, Footscray

3076

Research Site, Epping

3500

Research Site, Hasselt

3600

Research Site, Genk

4029

Research Site, Herston

4032

Research Site, Chermside

Research Site, Debrecen

5000

Research Site, Adelaide

5063

Research Site, Fullarton

6009

Research Site, Nedlands

6042

Research Site, Lodelinsart

6725

Research Site, Szeged

7580

Research Site, Kuils River

10050

Research Site, George Town

10154

Research Site, Torino

11527

Research Site, Athens

13385

Research Site, Marseille

14561

Research Site, Athens

20089

Research Site, Rozzano MI

20099

Research Site, Sesto San Giovanni (MI)

20230

Research Site, Aguascalientes

20814

Research Site, Bethesda

21044

Research Site, Columbia

25030

Research Site, Besançon

25100

Research Site, Kuantan

28034

Research Site, Madrid

28046

Research Site, Madrid

28100

Research Site, Novara

29010

Research Site, Málaga

32216

Research Site, Jacksonville

33394

Research Site, Gijón

33604

Research Site, Pessac

35801

Research Site, Huntsville

36608

Research Site, Mobile

37170

Research Site, Chambray-lès-Tours

37830

Research Site, Oak Ridge

38100

Research Site, Hadera

40536

Research Site, Lexington

43614

Research Site, Toledo

44670

Research Site, Guadalajara

44710

Research Site, Canton

45147

Research Site, Essen

46321

Research Site, Munster

48670

Research Site, Midland

48708

Research Site, Bay City

55805

Research Site, Duluth

56303

Research Site, Saint Cloud

58122

Research Site, Fargo

65212

Research Site, Columbia

70433

Research Site, Covington

71110

Research Site, Heraklion

75015

Research Site, Paris

75216

Research Site, Dallas

76301

Research Site, Wichita Falls

78240

Research Site, San Luis Potosí City

79106

Research Site, Amarillo

80230

Research Site, Culiacán

90502

Research Site, Torrance

90822

Research Site, Long Beach

91031

Research Site, Jerusalem

92161

Research Site, San Diego

101990

Research Site, Moscow

119991

Research Site, Moscow

121552

Research Site, Moscow

650002

Research Site, Kemerovo

4781156

Research Site, Temuco

07450

Research Site, Ridgewood

B1906EHD

Research Site, La Plata

X5016KEH

Research Site, Córdoba

X5003DCE

Research Site, Córdoba

X5021FPI

Research Site, Córdoba

90620-001

Research Site, Porto Alegre

05403-000

Research Site, São Paulo

T2N 4Z6

Research Site, Calgary

V8R 4R2

Research Site, Victoria

R2H 2A6

Research Site, Winnipeg

A1B 3V6

Research Site, St. John's

B3H 3A7

Research Site, Halifax

N6A 5A5

Research Site, London

M5B 1W8

Research Site, Toronto

M5G 2C4

Research Site, Toronto

H7M 3L9

Research Site, Laval

H1T 2M4

Research Site, Montreal

G1V 4G5

Research Site, Québec

625 00

Research Site, Brno

500 05

Research Site, Hradec Králové

128 08

Research Site, Prague

762 75

Research Site, Zlín

Unknown

Research Site, Galway

1815 JD

Research Site, Alkmaar

1081 HV

Research Site, Amsterdam

1091 AC

Research Site, Amsterdam

8934 AD

Research Site, Leeuwarden

6532 SZ

Research Site, Nijmegen

3079 DZ

Research Site, Rotterdam

5042 AD

Research Site, Tilburg

3508 GZ

Research Site, Utrecht

8025 AB

Research Site, Zwolle

0424

Research Site, Oslo

32-500

Research Site, Chrzanów

47-200

Research Site, Kędzierzyn-Koźle

31-202

Research Site, Krakow

31-501

Research Site, Krakow

90-549

Research Site, Lodz

04-628

Research Site, Warsaw

0157

Research Site, Centurion

301-723

Research Site, Daejeon

463-707

Research Site, Seongnam-si, Gyeonggi-do

130-872

Research Site, Seoul

156-707

Research Site, Seoul

08035

Research Site, Barcelona

08907

Research Site, L'Hospitalet de Llobregat

413 45

Research Site, Gothenburg

171 76

Research Site, Stockholm

NE7 7DN

Research Site, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY